Safety Study & Effectiveness of Docetaxel With RAD001 and Bevacizumab in Men With Advanced Prostate Cancer

Share this content:
Safety Study & Effectiveness of Docetaxel With RAD001 and Bevacizumab in Men With Advanced Prostate Cancer

Sponsors and collaborators
Cedars-Sinai Medical Center
Novartis
Genentech

Contact
Koo Nguyen, BS
Phone: 310-423-7600
E-mail: koo.nguyen@cshs.org

Tina Tolbert, BA
Phone: 310-423-7600
E-mail: tina.tolbert@cshs.org

ClinicalTrials.gov Identifier
NCT00574769
You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters